Efficacy and Safety of Envafolimab Combined With Capecitabine and Lenvatinib as Postoperative Adjuvant Therapy in Resected Biliary Tract Cancer With High‐Risk Recurrence Factors: A Phase II Single‐Center Prospective Study.
Saved in:
| Title: | Efficacy and Safety of Envafolimab Combined With Capecitabine and Lenvatinib as Postoperative Adjuvant Therapy in Resected Biliary Tract Cancer With High‐Risk Recurrence Factors: A Phase II Single‐Center Prospective Study. |
|---|---|
| Authors: | Tian, Yitong1,2 (AUTHOR), Lei, Tian1 (AUTHOR), Ruan, Qingyang3 (AUTHOR), Zhou, Xueying1,2 (AUTHOR), Shen, Ruijing1,2 (AUTHOR), Xie, Tianao1,2 (AUTHOR), Li, Shijie1,2 (AUTHOR), Cai, Xiujun1,2 (AUTHOR) srrsh_cxj@zju.edu.cn, Chen, Mingyu1,2 (AUTHOR) mychen@zju.edu.cn |
| Source: | Cancer Medicine. Apr2026, Vol. 15 Issue 4, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 193257950 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and Safety of Envafolimab Combined With Capecitabine and Lenvatinib as Postoperative Adjuvant Therapy in Resected Biliary Tract Cancer With High‐Risk Recurrence Factors: A Phase II Single‐Center Prospective Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Tian%2C+Yitong%22">Tian, Yitong</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lei%2C+Tian%22">Lei, Tian</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ruan%2C+Qingyang%22">Ruan, Qingyang</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Xueying%22">Zhou, Xueying</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shen%2C+Ruijing%22">Shen, Ruijing</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xie%2C+Tianao%22">Xie, Tianao</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Shijie%22">Li, Shijie</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cai%2C+Xiujun%22">Cai, Xiujun</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> srrsh_cxj@zju.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Chen%2C+Mingyu%22">Chen, Mingyu</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> mychen@zju.edu.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Medicine%22">Cancer Medicine</searchLink>. Apr2026, Vol. 15 Issue 4, p1-11. 11p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=193257950 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cam4.71756 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 1 Titles: – TitleFull: Efficacy and Safety of Envafolimab Combined With Capecitabine and Lenvatinib as Postoperative Adjuvant Therapy in Resected Biliary Tract Cancer With High‐Risk Recurrence Factors: A Phase II Single‐Center Prospective Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tian, Yitong – PersonEntity: Name: NameFull: Lei, Tian – PersonEntity: Name: NameFull: Ruan, Qingyang – PersonEntity: Name: NameFull: Zhou, Xueying – PersonEntity: Name: NameFull: Shen, Ruijing – PersonEntity: Name: NameFull: Xie, Tianao – PersonEntity: Name: NameFull: Li, Shijie – PersonEntity: Name: NameFull: Cai, Xiujun – PersonEntity: Name: NameFull: Chen, Mingyu IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 04 Text: Apr2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 20457634 Numbering: – Type: volume Value: 15 – Type: issue Value: 4 Titles: – TitleFull: Cancer Medicine Type: main |
| ResultId | 1 |